You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

Details for Patent: 10,342,762


✉ Email this page to a colleague

« Back to Dashboard


Which drugs does patent 10,342,762 protect, and when does it expire?

Patent 10,342,762 protects DSUVIA and is included in one NDA.

This patent has seventy-four patent family members in twelve countries.

Summary for Patent: 10,342,762
Title:Small-volume oral transmucosal dosage forms
Abstract: Small-volume oral transmucosal dosage forms or NanoTabs.RTM. comprising a predetermined amount of a pharmaceutically active drug are provided. Exemplary applications include use of the NanoTabs.RTM. to administer a drug for the treatment of acute, post-operative or breakthrough pain.
Inventor(s): Palmer; Pamela (San Francisco, CA), Schreck; Thomas (Portola Valley, CA), Tzannis; Stelios (Petaluma, CA), Hamel; Lawrence (Pacific Grove, CA), Poutiatine; Andrew I. (Mill Valley, CA)
Assignee: AcelRx Pharmaceuticals, Inc. (Redwood City, CA)
Application Number:14/296,992
Patent Claim Types:
see list of patent claims
Composition; Delivery; Device; Dosage form;
Patent landscape, scope, and claims:

Understanding the Scope and Claims of a US Patent: A Detailed Analysis of US Patent 10,342,762

Introduction

When navigating the complex world of patents, understanding the scope and claims of a patent is crucial for inventors, businesses, and legal professionals. This article will delve into the specifics of US Patent 10,342,762, using it as a case study to explain the broader concepts of patent scope, claims, and the patent landscape in the United States.

What is a Patent?

A patent is a government-granted right that allows the patent holder to exclude others from making, using, or selling an invention for a specified period, typically 20 years from the filing date of the patent application[5].

The Role of the USPTO

The U.S. Patent and Trademark Office (USPTO) is the agency responsible for granting U.S. patents and registering trademarks. The USPTO plays a critical role in evaluating patent applications to ensure that the inventions meet the criteria of novelty, non-obviousness, and usefulness[5].

Patent Scope and Claims

Definition of Patent Scope

Patent scope refers to the breadth and depth of protection afforded by a patent. It is determined by the language of the patent claims, which define the boundaries of what is protected by the patent. The scope can be measured using metrics such as independent claim length and independent claim count[3].

Importance of Patent Claims

Patent claims are the heart of a patent application. They specify what the inventor considers to be the invention and define the scope of the protection sought. Claims must be clear, concise, and supported by the description in the patent application. The clarity and breadth of claims can significantly impact the patent's enforceability and its value to the inventor[3].

Analyzing US Patent 10,342,762

Patent Title and Abstract

To begin, it is essential to review the title and abstract of the patent. The title provides a brief description of the invention, while the abstract offers a more detailed summary. For example, if US Patent 10,342,762 is titled "Method and System for [Specific Invention]," the abstract would outline the key features and benefits of this method or system.

Independent and Dependent Claims

  • Independent Claims: These claims stand alone and define the invention without reference to other claims. They are crucial because they set the broadest boundaries of the patent's scope.
  • Dependent Claims: These claims refer back to and further limit the independent claims. They often provide additional details or specific embodiments of the invention.

Claim Language and Scope

The language used in the claims is critical. For instance, if a claim in US Patent 10,342,762 uses broad terms like "a method for" or "a system comprising," it may indicate a wider scope of protection. Conversely, more specific language can narrow the scope but may also make the patent more defensible against challenges[3].

Determining Inventorship

True and Only Inventors

US patent law requires that only the true and only inventors be listed on the patent application. This is a two-step process involving the conception of the idea and the reduction of the idea to practice. Errors in inventorship can lead to the patent being invalid and unenforceable if there is deceptive intent[2].

Correcting Inventorship Errors

While errors in inventorship can be corrected even after a patent is issued, any deceptive intent in naming inventors can render the patent unenforceable. Ensuring accurate inventorship is a critical aspect of maintaining the validity of a patent[2].

Patent Allowance Rates

Understanding the probability of receiving a patent is also important. The USPTO tracks various metrics such as the first-action allowance rate, progenitor allowance rate, and family allowance rate. These rates provide insights into the likelihood of a patent being granted based on different criteria, such as the origin of the application and the technology field[1].

Technology Fields and Classification

Patents are classified into various technology fields, which can affect the examination process and the scope of the patent. For example, patents in the fields of Chemical, Drugs and Medical, Electrical and Electronics, Computers and Communications, Mechanical, and Other are treated differently due to their unique characteristics and the expertise required for examination[1].

Data and Statistics

Access to comprehensive patent data is essential for analyzing the patent landscape. Databases like PatentsView provide detailed information on patent applications, grants, citations, and other relevant data. This data can help in understanding trends, identifying key players, and assessing the competitive landscape in various technology fields[4].

Case Study: US Patent 10,342,762

Claim Analysis

  • Independent Claim 1: This claim might read, "A method for [specific process], comprising [key steps or components]." Analyzing this claim would involve understanding the breadth of the process and the specific steps or components that are protected.
  • Dependent Claims: These might further specify particular embodiments or additional features of the method or system, such as "The method of claim 1, wherein [specific detail]."

Scope and Breadth

The scope of US Patent 10,342,762 would be determined by the combination of its independent and dependent claims. A broader scope could provide wider protection but might also face more challenges during the examination process or in litigation.

Inventorship and Ownership

Ensuring that the correct inventors are listed and that there is no deceptive intent is vital. This involves verifying the conception and reduction to practice by the listed inventors and ensuring that all contributors are properly recognized.

Patent Landscape and Trends

Current Trends in Patent Filings

The number of patent filings and grants can indicate trends in innovation and technological advancement. For instance, an increase in filings in the Electrical and Electronics field might suggest a surge in innovation related to smart technologies or renewable energy.

Competitive Analysis

Analyzing the patent landscape involves identifying key players and their patent portfolios. This can help in understanding market positions, potential licensing opportunities, and litigation risks.

Key Takeaways

  • Patent Scope and Claims: The scope of a patent is defined by its claims, which must be clear, concise, and supported by the patent description.
  • Inventorship: Accurate determination of inventorship is crucial to maintain the validity and enforceability of a patent.
  • Patent Allowance Rates: Understanding the probability of receiving a patent based on various metrics can help in strategizing the patent application process.
  • Technology Fields: Patents are classified into different technology fields, each with its own examination process and scope considerations.
  • Data Analysis: Access to comprehensive patent data is essential for analyzing trends, identifying key players, and assessing the competitive landscape.

FAQs

What is the significance of independent claims in a patent?

Independent claims define the broadest boundaries of the patent's scope and stand alone without reference to other claims.

How does the USPTO classify patents into different technology fields?

The USPTO uses classification schemes such as the NBER classification to aggregate over 500 technology classes into broad fields like Chemical, Drugs and Medical, Electrical and Electronics, etc.[1].

What are the consequences of incorrect inventorship in a patent application?

Incorrect inventorship, especially with deceptive intent, can render the patent invalid and unenforceable[2].

How can patent data be used to analyze the patent landscape?

Patent data can be used to identify trends, key players, and the competitive landscape in various technology fields, helping in strategic decision-making[4].

What is the role of the USPTO in the patent process?

The USPTO is responsible for evaluating patent applications to ensure they meet the criteria of novelty, non-obviousness, and usefulness, and for granting U.S. patents and registering trademarks[5].

Sources

  1. Carley, M., & Hegde, D. (n.d.). What Is the Probability of Receiving a US Patent?. Retrieved from https://yjolt.org/sites/default/files/carley_hegde_marco-what_is_the_probability_of_receiving_a_us_patent_0.pdf
  2. Gattari, D. (n.d.). Determining Inventorship for US Patent Applications. Retrieved from https://agsci.oregonstate.edu/sites/agsci/files/main/research/vrc_release_inventorship-gattari.pdf
  3. Hoover Institution. (2016). Patent Claims and Patent Scope. Retrieved from https://www.hoover.org/sites/default/files/ip2-wp16001-paper.pdf
  4. PatentsView. (n.d.). Data Download Tables. Retrieved from https://patentsview.org/download/data-download-tables
  5. U.S. Patent and Trademark Office. (n.d.). U.S. Patent and Trademark Office (USPTO). Retrieved from https://www.usa.gov/agencies/u-s-patent-and-trademark-office

More… ↓

⤷  Subscribe


Drugs Protected by US Patent 10,342,762

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Vertical Pharms DSUVIA sufentanil citrate TABLET;SUBLINGUAL 209128-001 Nov 2, 2018 RX Yes Yes 10,342,762 ⤷  Subscribe Y ⤷  Subscribe
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

International Family Members for US Patent 10,342,762

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
European Patent Office 2114383 ⤷  Subscribe 300797 Netherlands ⤷  Subscribe
European Patent Office 2114383 ⤷  Subscribe CA 2016 00007 Denmark ⤷  Subscribe
European Patent Office 2114383 ⤷  Subscribe CR 2016 00007 Denmark ⤷  Subscribe
European Patent Office 2114383 ⤷  Subscribe 122016000023 Germany ⤷  Subscribe
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.